In the article on the Phase I Study of Bortezomib in Leukemias in the May 15, 2004 issue of Clinical Cancer Research, there was an error in authorship. The correct list of authors is, as follows:

Jorge Cortes, Deborah Thomas, Charles Koller, Frances Giles, Elihu Estey, Stefan Faderl, Guillermo Garcia-Manero, David McConkey, Stacey L. Ruiz, Roberto Guerciolini, John Wright, and Hagop Kantarjian.

Cortes J, Thomas D, Koller C, et al: Phase I Study of Bortezomib in Refractory or Relapsed Acute Leukemias. Clin Cancer Res 2004;10:3371–77.